Literature DB >> 29257741

Use of hydrogel spacer for improved rectal dose-sparing in patients undergoing radical radiotherapy for localized prostate cancer: First Canadian experience.

Alejandro Berlin1, Anne Di Tomasso1, Heather Ballantyne1, Susan Patterson1, Tony Lam1, Aravind Sundaramurthy1, Joelle Helou1, Andrew Bayley1, Peter Chung1.   

Abstract

We describe the initial experience using a hydrogel spacer (SpaceOAR) to separate the prostate-rectum interspace in patients planned to undergo radical hypofractionated, image-guided, intensity-modulated radiotherapy (IG-IMRT). We depict and discuss the impact of SpaceOAR in the context of hypofractionated IG-IMRT, and the particular considerations for its applications in the Canadian setting.

Entities:  

Year:  2017        PMID： 29257741      PMCID： PMC5962942          DOI： 10.5489/cuaj.4681

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN： 1911-6470            Impact factor:   1.862


  10 in total

Review 1.  Short-term androgen deprivation therapy for patients with intermediate-risk prostate cancer undergoing dose-escalated radiotherapy: the standard of care?

Authors:  Zachary S Zumsteg; Michael J Zelefsky
Journal:  Lancet Oncol       Date:  2012-06       Impact factor: 41.316

2.  Spacer application for prostate cancer radiation therapy.

Authors:  Michael Pinkawa
Journal:  Future Oncol       Date:  2014-04       Impact factor: 3.404

3.  Randomized Trial of a Hypofractionated Radiation Regimen for the Treatment of Localized Prostate Cancer.

Authors:  Charles N Catton; Himu Lukka; Chu-Shu Gu; Jarad M Martin; Stéphane Supiot; Peter W M Chung; Glenn S Bauman; Jean-Paul Bahary; Shahida Ahmed; Patrick Cheung; Keen Hun Tai; Jackson S Wu; Matthew B Parliament; Theodoros Tsakiridis; Tom B Corbett; Colin Tang; Ian S Dayes; Padraig Warde; Tim K Craig; Jim A Julian; Mark N Levine
Journal:  J Clin Oncol       Date:  2017-03-15       Impact factor: 44.544

4.  Hydrogel Spacer Prospective Multicenter Randomized Controlled Pivotal Trial: Dosimetric and Clinical Effects of Perirectal Spacer Application in Men Undergoing Prostate Image Guided Intensity Modulated Radiation Therapy.

Authors:  Neil Mariados; John Sylvester; Dhiren Shah; Lawrence Karsh; Richard Hudes; David Beyer; Steven Kurtzman; Jeffrey Bogart; R Alex Hsi; Michael Kos; Rodney Ellis; Mark Logsdon; Shawn Zimberg; Kevin Forsythe; Hong Zhang; Edward Soffen; Patrick Francke; Constantine Mantz; Peter Rossi; Theodore DeWeese; Daniel A Hamstra; Walter Bosch; Hiram Gay; Jeff Michalski
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-04-23       Impact factor: 7.038

5.  Continued Benefit to Rectal Separation for Prostate Radiation Therapy: Final Results of a Phase III Trial.

Authors:  Daniel A Hamstra; Neil Mariados; John Sylvester; Dhiren Shah; Lawrence Karsh; Richard Hudes; David Beyer; Steven Kurtzman; Jeffrey Bogart; R Alex Hsi; Michael Kos; Rodney Ellis; Mark Logsdon; Shawn Zimberg; Kevin Forsythe; Hong Zhang; Edward Soffen; Patrick Francke; Constantine Mantz; Peter Rossi; Theodore DeWeese; Stephanie Daignault-Newton; Benjamin W Fischer-Valuck; Anupama Chundury; Hiram Gay; Walter Bosch; Jeff Michalski
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-12-23       Impact factor: 7.038

6.  Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): acute toxicity results from a randomised non-inferiority phase 3 trial.

Authors:  Shafak Aluwini; Floris Pos; Erik Schimmel; Emile van Lin; Stijn Krol; Peter Paul van der Toorn; Hanja de Jager; Maarten Dirkx; Wendimagegn Ghidey Alemayehu; Ben Heijmen; Luca Incrocci
Journal:  Lancet Oncol       Date:  2015-02-03       Impact factor: 41.316

7.  Cancer incidence, mortality and survival trends in Canada, 1970-2007.

Authors:  L Kachuri; P De; L F Ellison; R Semenciw
Journal:  Chronic Dis Inj Can       Date:  2013-03

8.  Improved clinical outcomes with high-dose image guided radiotherapy compared with non-IGRT for the treatment of clinically localized prostate cancer.

Authors:  Michael J Zelefsky; Marisa Kollmeier; Brett Cox; Anthony Fidaleo; Dahlia Sperling; Xin Pei; Brett Carver; Jonathan Coleman; Michael Lovelock; Margie Hunt
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-02-11       Impact factor: 7.038

9.  Decision analysis model evaluating the cost of a temporary hydrogel rectal spacer before prostate radiation therapy to reduce the incidence of rectal complications.

Authors:  Ryan C Hutchinson; Varun Sundaram; Michael Folkert; Yair Lotan
Journal:  Urol Oncol       Date:  2016-03-30       Impact factor: 3.498

10.  Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial.

Authors:  David Dearnaley; Isabel Syndikus; Helen Mossop; Vincent Khoo; Alison Birtle; David Bloomfield; John Graham; Peter Kirkbride; John Logue; Zafar Malik; Julian Money-Kyrle; Joe M O'Sullivan; Miguel Panades; Chris Parker; Helen Patterson; Christopher Scrase; John Staffurth; Andrew Stockdale; Jean Tremlett; Margaret Bidmead; Helen Mayles; Olivia Naismith; Chris South; Annie Gao; Clare Cruickshank; Shama Hassan; Julia Pugh; Clare Griffin; Emma Hall
Journal:  Lancet Oncol       Date:  2016-06-20       Impact factor: 41.316
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.